MedPath

Oxybutynin Chloride

Oxybutynin Chloride Tablets, USP Rx only

Approved
Approval ID

3418ca19-feb0-9821-e063-6394a90ae819

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 1, 2025

Manufacturers
FDA

AvKARE

DUNS: 796560394

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Oxybutynin Chloride

PRODUCT DETAILS

NDC Product Code42291-456
Application NumberANDA208165
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateMay 1, 2025
Generic NameOxybutynin Chloride

INGREDIENTS (5)

FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, PREGELATINIZED CORNInactive
Code: O8232NY3SJ
Classification: IACT
OXYBUTYNIN CHLORIDEActive
Quantity: 5 mg in 1 1
Code: L9F3D9RENQ
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Oxybutynin Chloride - FDA Drug Approval Details